Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A patient with lupus and long-term hair loss saw significant hair regrowth after using the drug tofacitinib.

Cetuximab can cause unusual hair growth and hair loss.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Ruxolitinib can cause a delayed skin reaction on the nose.

Ruxolitinib helped a patient with alopecia areata regrow hair.

Cimicifuga racemosa extract may help prevent and treat prostate issues by inhibiting 5α-reductase.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The treatment showed high response rates and was well-tolerated, potentially extending patient survival.

Tofacitinib partially improved hair regrowth in a patient with severe hair loss.

Further research is needed to develop effective cancer prevention strategies.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Upadacitinib effectively treated severe atopic dermatitis, vitiligo, and alopecia areata in one patient.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Tofacitinib is effective and safe for treating severe alopecia areata and related conditions.

Tirzepatide may improve hair loss by reducing insulin resistance.

Two drugs, tofacitinib and ruxolitinib, may help regrow hair by activating hair follicles.

Upadacitinib successfully regrew hair in a child with alopecia universalis and specific genetic mutations.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Imuvert can prevent some chemotherapy-induced hair loss.

A new compound shows promise as a topical treatment for hair loss.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

A man developed a rash similar to pityriasis rubra pilaris after starting sorafenib for cancer, possibly due to the drug's effect on skin cells.